Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Details 2)

v3.20.2
Summary of Significant Accounting Policies (Details 2) - shares
3 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Antidilutive securities 42,766,174 40,786,621
Series A Preferred Stock    
Antidilutive securities [1] 750,000 750,000
Series B Preferred Stock    
Antidilutive securities [2] 1,160,240 1,160,240
Series C Preferred Stock    
Antidilutive securities [3] 2,318,012 2,318,012
Amended and Restated 2016 (formerly 2008) Stock Incentive Plan and 2019 Omnibus Equity Incentive Plan    
Antidilutive securities 11,948,088 10,003,088
Warrant    
Antidilutive securities 26,589,834 26,555,281
[1] Assumes exchange under the terms of the October 11, 2012 Note Exchange and Purchase Agreement, as amended.
[2] Assumes exchange under the terms of the Certificate of Designation of the Relative Rights and Preferences of the Series B 10% Convertible Preferred Stock, effective May 5, 2015; excludes shares of unegistered common stock issuable in payment of dividends on Series B Preferred upon conversion.
[3] Assumes exchange under the terms of the Certificate of Designation of the Relative Rights and Preferences of the Series C Convertible Preferred Stock, effective January 25, 2016.